Analysis Of Herpes Zoster

1570 Words4 Pages

Introduction
Herpes Zoster (HZ), or Shingles, is a cutaneous disease, characterized by a unilateral, dermatomal, and often painful vesicular rash. Following the primary infection of varicella zoster virus (VZV), the virus remains latent in the dorsal or cranial sensory ganglia. The outbreak typically results from reactivation of latent VZV.1 Herpes zoster (HZ) arises years or decades after primary infection with VZV, which is known in clinical settings as varicella and, in many instances, as chicken pox.1 HZ is primarily a disease in older adults or individuals with a weakened immune system. VZV is responsible for an estimated four cases of herpes zoster infection per one thousand people per year, with approximately 50% of these cases affecting patients at least 50 years old.1, 2 The number of incidences tends to increase proportionally with advancing age. Approximately 10-20% of the United States population will develop HZ, and about 50% are predicted to develop HZ in their life by the time they are 85.1, 2 Even though the number of people in the United States who get chickenpox each year has declined dramatically due to vaccinations, clinicians need to be educated about preventative strategies along with the current treatment options. This paper addresses correlating signs and symptoms of HZ, as well as existing treatments of acute HZ and post-herpetic neuralgia. It outlines current treatment strategies, along with deficiency of newest drugs and procedure implementations.
Clinical Presentation
HZ patients typically present with a characteristic, distinguishing unilateral, localized, vesicular eruption in dermatome distribution, that is often followed by an intensive localized prodromal pain. In rare instances, it is acco...

... middle of paper ...

... provider experience, management is often insufficient. Enhanced application of available treatment options, use of updated resources, complex approach to PHN management may play a superior role in treatment. Primary care is on the front line of patient care, diagnoses, and treatment. It plays an essential and crucial role in the development and execution of the PHN treatment plan. Patient treatment might be affected by multiple factors, ranging from medication compliance and side effects to drug cost. Sufficient management should be achieved starting with single drug, titrating additional treatment options as needed. Severe cases of PHN should be followed up by the use of topical anesthetic agents and paravertebral injections, if other means of therapy fail. Systematized and thoughtful PHN therapy will ensure sufficient pain relief and decrease the risk for PHN.

Open Document